IUIS relationship with the World Health Organization

September 15, 2017

 

IUIS has long had an informal relationship with the World Health Organisation (WHO). In 2017, this relationship was formalized according to WHO guidelines. The goal of the collaboration is to advance WHO’s work on quality, safety and efficacy of medical biological products with IUIS providing relevant expert immunology knowledge. Our new relationship involves planned contributions from IUIS and its members.

Specifically, we will work together on the WHO Programme Area: access to medicines and health technologies and strengthening regulatory capacity.

 

IUIS will provide support and knowledge in determining norms and standards for biologicals, especially vaccines, and scientific input on nomenclature of immunology molecules. We also support educational activities and communication to strengthen expertise in immunology.

 

We are grateful to Ivana Knezevic, who is our WHO liaison and has helped us immensely in creating this collaboration. We look forward to some exciting outcomes in the next three years.

More News

2021 Edition: Day of Immunology

June 17, 2021

2021 International Day of Immunology

June 7, 2021

Chinese Society for Immunology (CSI) Training Courses in 2020

March 4, 2021

Michelson Prizes

March 4, 2021

FUNDING OPPORTUNITY FROM IUIS AND FOCIS FOR IMMUNOLOGISTS FROM THE DEVELOPING WORLD – For Participation in Virtual Advanced Course in Basic & Clinical Immunology on March 1-3, 2021, USA

February 17, 2021

New Webinar Series: Immunology without Borders

February 2, 2021

IUIS/AAI AWARDS: SUMMER COURSES in IMMUNOLOGY

January 18, 2021

News from ICLAS

December 17, 2020

GEC Statement on the Publication “The association between early career informal mentorship in academic collaborations and junior author performance”

December 16, 2020